High-capacity adenovector delivery of forced CRISPR-Cas9 heterodimers fosters precise chromosomal deletions in human cells

Genome editing based on dual CRISPR-Cas9 complexes (multiplexes) permits removing specific genomic sequences in living cells leveraging research on functional genomics and genetic therapies. Delivering the required large and multicomponent reagents in a synchronous and stoichiometric manner remains,...

Full description

Bibliographic Details
Main Authors: Francesca Tasca, Marcella Brescia, Jin Liu, Josephine M. Janssen, Kamel Mamchaoui, Manuel A.F.V. Gonçalves
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253123000458
_version_ 1827994144057851904
author Francesca Tasca
Marcella Brescia
Jin Liu
Josephine M. Janssen
Kamel Mamchaoui
Manuel A.F.V. Gonçalves
author_facet Francesca Tasca
Marcella Brescia
Jin Liu
Josephine M. Janssen
Kamel Mamchaoui
Manuel A.F.V. Gonçalves
author_sort Francesca Tasca
collection DOAJ
description Genome editing based on dual CRISPR-Cas9 complexes (multiplexes) permits removing specific genomic sequences in living cells leveraging research on functional genomics and genetic therapies. Delivering the required large and multicomponent reagents in a synchronous and stoichiometric manner remains, however, challenging. Moreover, uncoordinated activity of independently acting CRISPR-Cas9 multiplexes increases the complexity of genome editing outcomes. Here, we investigate the potential of fostering precise multiplexing genome editing using high-capacity adenovector particles (AdVPs) for the delivery of Cas9 ortholog fusion constructs alone (forced Cas9 heterodimers) or together with their cognate guide RNAs (forced CRISPR-Cas9 heterodimers). We demonstrate that the efficiency and accuracy of targeted chromosomal DNA deletions achieved by single AdVPs encoding forced CRISPR-Cas9 heterodimers is superior to that obtained when the various components are delivered separately. Finally, all-in-one AdVP delivery of forced CRISPR-Cas9 heterodimers triggers robust DMD exon 51 splice site excision resulting in reading frame restoration and selection-free detection of dystrophin in muscle cells derived from Duchenne muscular dystrophy patients. In conclusion, AdVPs promote precise multiplexing genome editing through the integrated delivery of forced CRISPR-Cas9 heterodimer components, which, in comparison with split conventional CRISPR-Cas9 multiplexes, engage target sequences in a more coordinated fashion.
first_indexed 2024-04-10T04:35:28Z
format Article
id doaj.art-bd14d663ff8f4e04a1281686f5c0d2d9
institution Directory Open Access Journal
issn 2162-2531
language English
last_indexed 2024-04-10T04:35:28Z
publishDate 2023-03-01
publisher Elsevier
record_format Article
series Molecular Therapy: Nucleic Acids
spelling doaj.art-bd14d663ff8f4e04a1281686f5c0d2d92023-03-10T04:34:51ZengElsevierMolecular Therapy: Nucleic Acids2162-25312023-03-0131746762High-capacity adenovector delivery of forced CRISPR-Cas9 heterodimers fosters precise chromosomal deletions in human cellsFrancesca Tasca0Marcella Brescia1Jin Liu2Josephine M. Janssen3Kamel Mamchaoui4Manuel A.F.V. Gonçalves5Department of Cell and Chemical Biology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, the NetherlandsDepartment of Cell and Chemical Biology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, the NetherlandsDepartment of Cell and Chemical Biology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, the NetherlandsDepartment of Cell and Chemical Biology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, the NetherlandsSorbonne Université, Inserm, Institut de Myologie, Centre de Recherche en Myologie, Paris, FranceDepartment of Cell and Chemical Biology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, the Netherlands; Corresponding author: Manuel A.F.V. Gonçalves, Department of Cell and Chemical Biology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, the Netherlands.Genome editing based on dual CRISPR-Cas9 complexes (multiplexes) permits removing specific genomic sequences in living cells leveraging research on functional genomics and genetic therapies. Delivering the required large and multicomponent reagents in a synchronous and stoichiometric manner remains, however, challenging. Moreover, uncoordinated activity of independently acting CRISPR-Cas9 multiplexes increases the complexity of genome editing outcomes. Here, we investigate the potential of fostering precise multiplexing genome editing using high-capacity adenovector particles (AdVPs) for the delivery of Cas9 ortholog fusion constructs alone (forced Cas9 heterodimers) or together with their cognate guide RNAs (forced CRISPR-Cas9 heterodimers). We demonstrate that the efficiency and accuracy of targeted chromosomal DNA deletions achieved by single AdVPs encoding forced CRISPR-Cas9 heterodimers is superior to that obtained when the various components are delivered separately. Finally, all-in-one AdVP delivery of forced CRISPR-Cas9 heterodimers triggers robust DMD exon 51 splice site excision resulting in reading frame restoration and selection-free detection of dystrophin in muscle cells derived from Duchenne muscular dystrophy patients. In conclusion, AdVPs promote precise multiplexing genome editing through the integrated delivery of forced CRISPR-Cas9 heterodimer components, which, in comparison with split conventional CRISPR-Cas9 multiplexes, engage target sequences in a more coordinated fashion.http://www.sciencedirect.com/science/article/pii/S2162253123000458MT: RNA/DNA Editingmultiplexing gene editinggene deliveryfusion Cas9 proteinshigh-capacity adenoviral vectorson-target specificity
spellingShingle Francesca Tasca
Marcella Brescia
Jin Liu
Josephine M. Janssen
Kamel Mamchaoui
Manuel A.F.V. Gonçalves
High-capacity adenovector delivery of forced CRISPR-Cas9 heterodimers fosters precise chromosomal deletions in human cells
Molecular Therapy: Nucleic Acids
MT: RNA/DNA Editing
multiplexing gene editing
gene delivery
fusion Cas9 proteins
high-capacity adenoviral vectors
on-target specificity
title High-capacity adenovector delivery of forced CRISPR-Cas9 heterodimers fosters precise chromosomal deletions in human cells
title_full High-capacity adenovector delivery of forced CRISPR-Cas9 heterodimers fosters precise chromosomal deletions in human cells
title_fullStr High-capacity adenovector delivery of forced CRISPR-Cas9 heterodimers fosters precise chromosomal deletions in human cells
title_full_unstemmed High-capacity adenovector delivery of forced CRISPR-Cas9 heterodimers fosters precise chromosomal deletions in human cells
title_short High-capacity adenovector delivery of forced CRISPR-Cas9 heterodimers fosters precise chromosomal deletions in human cells
title_sort high capacity adenovector delivery of forced crispr cas9 heterodimers fosters precise chromosomal deletions in human cells
topic MT: RNA/DNA Editing
multiplexing gene editing
gene delivery
fusion Cas9 proteins
high-capacity adenoviral vectors
on-target specificity
url http://www.sciencedirect.com/science/article/pii/S2162253123000458
work_keys_str_mv AT francescatasca highcapacityadenovectordeliveryofforcedcrisprcas9heterodimersfostersprecisechromosomaldeletionsinhumancells
AT marcellabrescia highcapacityadenovectordeliveryofforcedcrisprcas9heterodimersfostersprecisechromosomaldeletionsinhumancells
AT jinliu highcapacityadenovectordeliveryofforcedcrisprcas9heterodimersfostersprecisechromosomaldeletionsinhumancells
AT josephinemjanssen highcapacityadenovectordeliveryofforcedcrisprcas9heterodimersfostersprecisechromosomaldeletionsinhumancells
AT kamelmamchaoui highcapacityadenovectordeliveryofforcedcrisprcas9heterodimersfostersprecisechromosomaldeletionsinhumancells
AT manuelafvgoncalves highcapacityadenovectordeliveryofforcedcrisprcas9heterodimersfostersprecisechromosomaldeletionsinhumancells